Behavior of host-cell-protein-rich aggregates in antibody capture and polishing chromatography

[1]  L. Choe,et al.  Analytical characterization of host‐cell‐protein‐rich aggregates in monoclonal antibody solutions , 2023, Biotechnology progress.

[2]  L. Choe,et al.  Characterization and implications of host‐cell protein aggregates in biopharmaceutical processing , 2022, Biotechnology and bioengineering.

[3]  Chen Qian,et al.  Formation of transient highly-charged mAb clusters strengthens interactions with host cell proteins and results in poor clearance of host cell proteins by protein A chromatography. , 2022, Journal of chromatography. A.

[4]  Kelvin H. Lee,et al.  Comprehensive assessment of host cell protein expression after extended culture and bioreactor production of CHO cell lines , 2022, Biotechnology and bioengineering.

[5]  Alana C Szkodny,et al.  Biopharmaceutical Manufacturing: Historical Perspectives and Future Directions. , 2022, Annual review of chemical and biomolecular engineering.

[6]  G. Gaza-Bulseco,et al.  “High‐risk” host cell proteins (HCPs): A multi‐company collaborative view , 2021, Biotechnology and bioengineering.

[7]  R. Molden,et al.  Host cell protein profiling of commercial therapeutic protein drugs as a benchmark for monoclonal antibody-based therapeutic protein development , 2021, mAbs.

[8]  A. Lenhoff,et al.  Displacement to separate host‐cell proteins and aggregates in cation‐exchange chromatography of monoclonal antibodies , 2020, Biotechnology and bioengineering.

[9]  Kurt Eyer,et al.  Chromatographic clarification overcomes chromatin‐mediated hitch‐hiking interactions on Protein A capture column , 2020, Biotechnology and bioengineering.

[10]  Z. Li,et al.  Strategies for high‐concentration drug substance manufacturing to facilitate subcutaneous administration: A review , 2020, Biotechnology and bioengineering.

[11]  M. Morbidelli,et al.  Understanding mAb aggregation during low pH viral inactivation and subsequent neutralization , 2019, Biotechnology and bioengineering.

[12]  Z. Li,et al.  Protein aggregation and mitigation strategy in low pH viral inactivation for monoclonal antibody purification , 2019, mAbs.

[13]  J. Bones,et al.  Identification and tracking of problematic host cell proteins removed by a synthetic, highly functionalized nonwoven media in downstream bioprocessing of monoclonal antibodies. , 2019, Journal of chromatography. A.

[14]  T. Schwab,et al.  Mass spectrometric evaluation of upstream and downstream process influences on host cell protein patterns in biopharmaceutical products , 2019, Biotechnology progress.

[15]  Xuankuo Xu,et al.  DNA RETENTION ON DEPTH FILTERS. , 2019, Journal of membrane science.

[16]  Gary Walsh,et al.  Biopharmaceutical benchmarks 2018 , 2018, Nature Biotechnology.

[17]  Ludovic C. Gillet,et al.  Data‐independent acquisition‐based SWATH‐MS for quantitative proteomics: a tutorial , 2018, Molecular systems biology.

[18]  Xuankuo Xu,et al.  Contributions of depth filter components to protein adsorption in bioprocessing , 2018, Biotechnology and bioengineering.

[19]  Timothy M Pabst,et al.  Evaluation of recent Protein A stationary phase innovations for capture of biotherapeutics. , 2018, Journal of chromatography. A.

[20]  Christine Carapito,et al.  Dual Data-Independent Acquisition Approach Combining Global HCP Profiling and Absolute Quantification of Key Impurities during Bioprocess Development. , 2018, Analytical chemistry.

[21]  Christopher Gillespie,et al.  Integrated flow-through purification for therapeutic monoclonal antibodies processing , 2018, mAbs.

[22]  Massimo Morbidelli,et al.  Design and operation of a continuous integrated monoclonal antibody production process , 2017, Biotechnology progress.

[23]  Lihua Huang,et al.  A Novel Sample Preparation for Shotgun Proteomics Characterization of HCPs in Antibodies. , 2017, Analytical chemistry.

[24]  Z. Li,et al.  Host Cell Protein Profiling by Targeted and Untargeted Analysis of Data Independent Acquisition Mass Spectrometry Data with Parallel Reaction Monitoring Verification. , 2017, Analytical chemistry.

[25]  Min Zhu,et al.  Effects of antibody disulfide bond reduction on purification process performance and final drug substance stability , 2017, Biotechnology and bioengineering.

[26]  A. Shukla,et al.  Evolving trends in mAb production processes , 2017, Bioengineering & translational medicine.

[27]  M. Xian,et al.  A simple and efficient purification platform for monoclonal antibody production based on chromatin-directed cell culture clarification integrated with precipitation and void-exclusion anion exchange chromatography. , 2016, Journal of biotechnology.

[28]  Rui Nian,et al.  Advance chromatin extraction enhances performance and productivity of cation exchange chromatography-based capture of Immunoglobulin G monoclonal antibodies. , 2016, Journal of chromatography. A.

[29]  P. Wright,et al.  Quantitative definition and monitoring of the host cell protein proteome using iTRAQ – a study of an industrial mAb producing CHO‐S cell line , 2016, Biotechnology journal.

[30]  Abraham M Lenhoff,et al.  Host cell protein impurities in chromatographic polishing steps for monoclonal antibody purification , 2016, Biotechnology and bioengineering.

[31]  Michael P. Hall,et al.  Characterization of the co‐elution of host cell proteins with monoclonal antibodies during protein A purification , 2016, Biotechnology progress.

[32]  A. Lenhoff,et al.  Characterization of cross-linked cellulosic ion-exchange adsorbents: 2. Protein sorption and transport. , 2016, Journal of chromatography. A.

[33]  Yuansheng Yang,et al.  Advance chromatin extraction improves capture performance of protein A affinity chromatography. , 2016, Journal of chromatography. A.

[34]  Jennifer Halley,et al.  Protein A chromatography increases monoclonal antibody aggregation rate during subsequent low pH virus inactivation hold , 2015, Journal of chromatography. A.

[35]  Rui Nian,et al.  Non-immunospecific association of immunoglobulin G with chromatin during elution from protein A inflates host contamination, aggregate content, and antibody loss. , 2015, Journal of chromatography. A.

[36]  D. Ecker,et al.  The therapeutic monoclonal antibody market , 2015, mAbs.

[37]  Giorgio Carta,et al.  Particle size effects on protein and virus-like particle adsorption on perfusion chromatography media. , 2015, Journal of chromatography. A.

[38]  Rui Nian,et al.  Chromatin-mediated depression of fractionation performance on electronegative multimodal chromatography media, its prevention, and ramifications for purification of immunoglobulin G. , 2014, Journal of chromatography. A.

[39]  J. Zhu-Shimoni,et al.  Host cell protein testing by ELISAs and the use of orthogonal methods , 2014, Biotechnology and bioengineering.

[40]  Gary Walsh,et al.  Biopharmaceutical benchmarks 2014 , 2014, Nature Biotechnology.

[41]  Brendan MacLean,et al.  MSstats: an R package for statistical analysis of quantitative mass spectrometry-based proteomic experiments , 2014, Bioinform..

[42]  David Robbins,et al.  A Novel Approach to Monitor Clearance of Host Cell Proteins Associated With Monoclonal Antibodies , 2014, Biotechnology progress.

[43]  Rui Nian,et al.  Nonspecific interactions of chromatin with immunoglobulin G and protein A, and their impact on purification performance. , 2014, Journal of chromatography. A.

[44]  Abraham M Lenhoff,et al.  Identification and characterization of host cell protein product‐associated impurities in monoclonal antibody bioprocessing , 2014, Biotechnology and bioengineering.

[45]  Massimo Morbidelli,et al.  Model-based prediction of monoclonal antibody retention in ion-exchange chromatography. , 2013, Journal of chromatography. A.

[46]  G. Carta,et al.  Protein and virus-like particle adsorption on perfusion chromatography media. , 2013, Journal of chromatography. A.

[47]  P. Gagnon,et al.  Characterization and removal of aggregates formed by nonspecific interaction of IgM monoclonal antibodies with chromatin catabolites during cell culture production. , 2013, Journal of chromatography. A.

[48]  Scott M Husson,et al.  Anion exchange membrane adsorbers for flow‐through polishing steps: Part II. Virus, host cell protein, DNA clearance, and antibody recovery , 2013, Biotechnology and bioengineering.

[49]  C. Smales,et al.  The challenges of product- and process-related impurities to an evolving biopharmaceutical industry. , 2013, Bioanalysis.

[50]  Ludovic C. Gillet,et al.  Targeted Data Extraction of the MS/MS Spectra Generated by Data-independent Acquisition: A New Concept for Consistent and Accurate Proteome Analysis* , 2012, Molecular & Cellular Proteomics.

[51]  J. Chon,et al.  Advances in the production and downstream processing of antibodies. , 2011, New biotechnology.

[52]  María Vázquez-Rey,et al.  Aggregates in monoclonal antibody manufacturing processes , 2011, Biotechnology and bioengineering.

[53]  R. Aebersold,et al.  mProphet: automated data processing and statistical validation for large-scale SRM experiments , 2011, Nature Methods.

[54]  Gary Walsh,et al.  Biopharmaceutical benchmarks 2010 , 2010, Nature Biotechnology.

[55]  John Hickey,et al.  Profiling of host cell proteins by two‐dimensional difference gel electrophoresis (2D‐DIGE): Implications for downstream process development , 2010, Biotechnology and bioengineering.

[56]  A. Hunter,et al.  Host cell proteins in biologics development: Identification, quantitation and risk assessment , 2009, Biotechnology and bioengineering.

[57]  P. Hinckley,et al.  Host cell protein clearance during protein a chromatography: Development of an improved column wash step , 2008, Biotechnology progress.

[58]  D. Roush,et al.  Advances in Primary Recovery: Centrifugation and Membrane Technology , 2008, Biotechnology progress.

[59]  Sean L Seymour,et al.  The Paragon Algorithm, a Next Generation Search Engine That Uses Sequence Temperature Values and Feature Probabilities to Identify Peptides from Tandem Mass Spectra*S , 2007, Molecular & Cellular Proteomics.

[60]  Brian Hubbard,et al.  Downstream processing of monoclonal antibodies--application of platform approaches. , 2007, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

[61]  Abraham M Lenhoff,et al.  Pore size distributions of ion exchangers and relation to protein binding capacity. , 2006, Journal of chromatography. A.

[62]  A. Lenhoff,et al.  Nondiffusive mechanisms enhance protein uptake rates in ion exchange particles , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[63]  D. W. Scott.  On optimal and data based histograms , 1979 .